Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I-a randomized, placebo-controlled, double-blind, Asian-Pacific trial.

Wai Poon,Christian Matula,Pieter E. Vos,Dafin F. Muresanu,N. Von Steinbüchel,K. von Wild,Volker Hömberg,Ernest W. Wang,Tatia M.C. Lee,Stefan Strilciuc,J. C. Vester

Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I-a randomized, placebo-controlled, double-blind, Asian-Pacific trial.

2019

Wai Poon
Christian Matula
Pieter E. Vos
Dafin F. Muresanu
N. Von Steinbüchel
K. von Wild
Volker Hömberg
Ernest W. Wang
Tatia M.C. Lee
Stefan Strilciuc
J. C. Vester

Objective To evaluate the safety and efficacy of Cerebrolysin as an add-on therapy to local standard treatment protocol in patients after moderate-to-severe traumatic brain injury.

Keywords:

Standard treatment
Traumatic brain injury
Anesthesia
Diabetes mellitus
Placebo
Cerebrolysin
Physical therapy
Medicine
Strictly standardized mean difference
Clinical endpoint
Population
Statistical significance
Randomized controlled trial
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations